XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue [1] $ 297,057 $ 215,071
Expenses    
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below) [1] 219,739 157,832
Selling, general and administrative expenses [1] 58,932 58,591
Depreciation and amortization expenses 15,106 15,187
Change in fair value of contingent consideration 6,078 (594)
Total operating expenses 299,855 231,016
Operating loss (2,798) (15,945)
Interest income 117 123
Interest expense (2,241) (6,337)
Gain from equity method investees 596 7,783
Gain on transfer of membership 0 22,969
Loss on repayment of debt, net 0 (19,158)
Other income (expense), net 178 (14)
Loss from continuing operations before income taxes (4,148) (10,579)
Provision for income taxes 1,202 611
Loss from continuing operations (5,350) (11,190)
Income from discontinued operations, net of tax 0 1,383
Net loss attributable to common shareholders of Evolent Health, Inc. - Basic (5,350) (9,807)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted $ (5,350) $ (9,807)
Basic    
Continuing operations (in dollars per share) $ (0.06) $ (0.13)
Discontinued operations (in dollars per share) 0 0.01
Basic loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) (0.06) (0.12)
Diluted    
Continuing operations (in dollars per share) (0.06) (0.13)
Discontinued operations (in dollars per share) 0 0.01
Diluted loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) $ (0.06) $ (0.12)
Weighted-average common shares outstanding    
Basic (in shares) 89,509 84,670
Diluted (in shares) 89,509 84,670
Comprehensive loss    
Net loss $ (5,350) $ (9,807)
Other comprehensive loss, net of taxes, related to:    
Foreign currency translation adjustment (132) (31)
Total comprehensive loss attributable to common shareholders of Evolent Health, Inc. $ (5,482) $ (9,838)
[1] See Note 18 for amounts attributable to unconsolidated related parties included in these line items.